Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,503 | 583 | 0 | 0 | 0 |
| Gross Profit | 1,503 | 583 | N/A | N/A | N/A |
| Operating Expenses | 15,822 | 16,055 | 113,392 | 37,446 | 52,811 |
| Operating Income | -14,320 | -15,472 | -113,392 | -37,446 | -52,811 |
| Other Income | 1,361 | 1,185 | 730 | 319 | -668 |
| Pre-tax Income | -12,959 | -14,287 | -112,662 | -37,127 | -53,479 |
| Net Income Continuous | -12,959 | -14,287 | -112,662 | -37,127 | -53,479 |
| Net Income | $-12,959 | $-14,287 | $-112,662 | $-37,127 | $-53,479 |
| EPS Basic Total Ops | -2.35 | -3.95 | -67.99 | -34.88 | -50.61 |
| EPS Basic Continuous Ops | -2.35 | -3.95 | -67.99 | -34.88 | -50.59 |
| EPS Diluted Total Ops | -2.35 | -3.95 | -67.99 | -34.88 | -50.61 |
| EPS Diluted Continuous Ops | -2.35 | -3.95 | -67.99 | -34.88 | -50.59 |
| EPS Diluted Before Non-Recurring Items | -2.35 | -3.95 | -31.75 | -34.80 | -50.60 |
| EBITDA(a) | $-14,297 | $-15,465 | $-113,206 | $-37,175 | $-52,582 |